UPDATE : Friday, January 24, 2020
FDA OKs Samsung Bioepis’ first oncology medicine
Samsung Bioepis said Monday that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2019-01-21 11:43
Celltrion wins patent dispute on Truxima
Celltrion said Friday that it has won the domestic patent appeal for chroni...
by Lee Han-soo  |  2019-01-18 11:47
Over 1,000 bio-ventures set up in past 3 years
Korea’s bio-venture business boom peaked in 2016 and turned downward, but a...
by Lee Han-soo  |  2019-01-17 22:05
CL Bio wins patent for substance that improves antidiabetic functions
CL Bio, a local biopharmaceutical firm, said Monday that it has acquired al...
by Lee Han-soo  |  2019-01-14 12:34
Medipost, LG Chem to develop stem cell therapy
Medipost said Monday that it has signed a cooperation agreement with LG Che...
by Lee Han-soo  |  2019-01-08 17:55
Samsung Bioepis to expand business in China
Samsung Bioepis has signed a licensing agreement with 3SBio, a Chinese biot...
by Lee Han-soo  |  2019-01-07 12:30
Celltrion’s Truxima claims 35% of European rituximab market
Celltrion Healthcare said Thursday that Truxima (Ingredient: rituximab-abbs...
by Lee Han-soo  |  2019-01-04 15:54
Alteogen wins patent on optimizing incubation conditions for Eylea biosimilar
Alteogen said Wednesday that it has registered a patent on quality improvem...
by Lee Han-soo  |  2019-01-03 16:01
Newly listed pharmaceuticals suffer market cap declines
Market capitalizations of pharmaceutical and biotech companies that went pu...
by Nam Doo-hyun  |  2018-12-21 15:13
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
The Financial Supervisory Service has begun to inspect Celltrion Healthcare...
by Nam Doo-hyun  |  2018-12-17 12:48
Samsung BioLogics’ market cap rises after accounting issue
Samsung BioLogics is still showing its robust status in the Korean stock ma...
by Nam Doo-hyun  |  2018-12-13 15:33
‘Bispecific antibody market offers promising outlook’
The treatment market using bispecific antibodies is likely to grow rapidly,...
by Nam Doo-hyun  |  2018-12-12 16:27
Samsung BioLogics, Celltrion shares soar despite uncertainty
The share prices of Samsung BioLogics and Celltrion rose Wednesday even tho...
by Lee Han-soo  |  2018-12-12 16:27
Machine learning finds biomarker for rare Castleman Disease
Medidata, a cloud-based solution provider for clinical research, said it ha...
by Lee Hye-seon  |  2018-12-11 17:11
Viromed finds prostate hyperplasia treatment effect in natural substance
A team of researchers at the Viromed’s natural product research group said ...
by Lee Han-soo  |  2018-12-11 14:55
Samsung BioLogics resumes trading despite controversies
The Korea Exchange (KRX) has decided to allow continued trading of Samsung ...
by Lee Han-soo  |  2018-12-11 10:50
Celltrion unveils clinical trial results for rituximab biosimilar in US
Celltrion Healthcare has presented a clinical trial, which showed the effic...
by Lee Han-soo  |  2018-12-06 11:11
Samsung BioLogics, Saint-Gobain sign supply agreement
Samsung BioLogics said Wednesday that it has signed a single-use raw materi...
by Lee Han-soo  |  2018-12-05 14:01
Chong Kun Dang launches world’s 1st 2nd-generation anemia biosimilar
Chong Kun Dang Pharmaceutical said Sunday that it has become the first comp...
by Lee Han-soo  |  2018-12-04 11:18
‘Rules to be tougher on patent transfer due to ToolGen case’
As the regulation on the patent transfer to a company from universities and...
by Nam Doo-hyun  |  2018-11-29 11:48
Back to Top